How to Taper Off Wegovy: Making the Right Decision for You

Why there is no standard taper-off schedule, and what that means for you

The licensed Wegovy schedule runs one direction: 0.25 mg, then 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg, each step roughly four weeks apart. The Patient Information Leaflet, the Summary of Product Characteristics, and the NHS medicines guidance on semaglutide describe dose escalation in detail, but none of them set out an equivalent step-down ladder, because clinical trials did not study formal tapering as a treatment strategy.

That gap matters. It means your question about how to taper off Wegovy does not have a single published answer you can copy. What it has is a clinical decision: your prescriber looks at your current dose, your reasons for stopping, and your overall health, then recommends a path. Some people stop from a lower maintenance dose; others reduce from 2.4 mg in steps that mirror the escalation in reverse. Neither is mandated. Both require a prescriber's sign-off.

The practical upshot is that if you are weighing whether to stop altogether or simply reduce for a period, the question of whether tapering is even necessary for you is worth settling first. It is a more nuanced question than most people expect, and the answer turns on your dose, your tolerance, and why you want to stop.

What the evidence says about stopping semaglutide

The clinical trial data here is genuinely important to understand before you make any decision. The STEP 1 trial, published in the New England Journal of Medicine, showed around 15% average weight reduction on semaglutide 2.4 mg over 68 weeks. A follow-up study then tracked what happened after participants stopped, and found that much of that weight returned within a year in the group that discontinued treatment, without ongoing lifestyle support. The medicine was doing active metabolic work; removing it without replacing that support tends to shift the balance back.

This is not a reason to stay on a medicine indefinitely if it is not right for you. It is a reason to plan. Stopping alongside a solid diet and activity routine is meaningfully different from stopping cold. Some people use a gradual reduction to give their appetite regulation time to adjust; others stop from a lower dose when they have already built robust habits. How fast weight loss happened on Wegovy can inform the picture too, the rate of loss varies considerably between individuals, and that context shapes what stopping looks like in practice.

There is also the question of what happens to the side effects you may have been managing. GI symptoms (nausea, changes in bowel habit, fatigue) typically ease as the dose comes down, which is one reason some people find a stepped reduction more comfortable than stopping abruptly from a higher dose.

Reasons people consider stopping, and which deserve a closer look

The decision to taper off Wegovy usually comes from one of a few places. Cost is a common one: Wegovy is a private prescription medicine and the monthly outlay adds up. If that is your reason, it is worth reading a straightforward comparison of what Wegovy costs through different UK providers before deciding, because what is included in the headline price varies more than most people realise. A transparent single price covering consultation, prescription, and aftercare looks different from a low pen price with add-on fees.

Side effects are another reason. If nausea or GI discomfort has been persistent, the answer is often a dose adjustment rather than full discontinuation, many people find symptoms improve when they stay at a lower dose for longer before moving up, or step back to a previous dose temporarily. Talking to your prescriber before stopping gives you that option.

Surgery or a planned medical procedure is a third scenario. Anaesthetists need to know you are on a GLP-1 medicine, and your surgical team may ask you to stop beforehand; NHS England's guidance on weight-management injections covers this clearly. In that case, stopping is a clinical instruction with a defined purpose, not a lifestyle choice, and the timing should follow what your team advises.

Whatever your reason, the right first move is to contact the clinical team who prescribes for you. If you want to understand what a structured step-down might look like in practice, a detailed look at how a Wegovy taper schedule is structured is a useful starting point before that conversation.

Planning what comes after: lifestyle, monitoring, and next steps

The practical side of stopping Wegovy is often less about the final injection and more about what comes next. Appetite, which semaglutide actively suppresses, does return after stopping, typically within a few weeks as the medicine clears. Having eating habits and activity patterns already embedded before you stop is the single biggest factor in how much ground is held afterward.

A few people keep a note in their phone of the date their last pen went into the fridge and count forward from there, which makes it easier to track when they might expect appetite to shift. Simple. Practical. Worth doing.

Monitoring your weight for the first three months after stopping is also sensible, not obsessively, but enough to catch early regain before it builds momentum. If regain does happen quickly, returning to treatment is not a failure; GLP-1 medicines are increasingly understood as long-term management tools rather than short courses. Your prescriber can discuss what re-starting would look like and whether Wegovy or the broader semaglutide landscape still suits you, or whether a different treatment would be a better fit. For a fuller picture of the medicine itself, the Wegovy treatment page covers its mechanism, eligibility, and what to expect. If you are ready to talk through your situation with a prescriber, you can start a free consultation with the nume team at any point.